Fisher Asset Management
RCUS icon

Fisher Asset Management’s Arcus Biosciences RCUS Stock Holding History

Fisher Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66M Sell
2,139,396
-51,008
-2% -$1.26M 0.02% 213
2026
Q1 		$47.3M Buy
2,190,404
+240,616
+12% +$5.2M 0.02% 244
2025
Q4 		$46.5M Buy
1,949,788
+1,220,635
+167% +$24.9M 0.02% 244
2025
Q3 		$9.92M Buy
729,153
+640,990
+727% +$6.66M ﹤0.01% 410
2025
Q2 		$718K Sell
88,163
-49,475
-36% -$423K ﹤0.01% 738
2025
Q1 		$1.08M Buy
+137,638
New +$1.6M ﹤0.01% 668

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Fisher Asset Management's RCUS Position: Q2 2026 in Review

Fisher Asset Management reduced its Arcus Biosciences (RCUS) stake by 2.3% in Q2 2026, selling an estimated $1.26M and leaving 2,139,396 shares worth $66M. The position accounts for 0.02% of the portfolio, ranked #213.

Fisher Asset Management first reported a position in RCUS in Q1 2025 and has held it in 6 quarters since. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Fisher Asset Management held 2,139,396 shares of Arcus Biosciences worth $66M as of Q2 2026.
  • Fisher Asset Management sold 51,008 Arcus Biosciences shares in Q2 2026, an estimated $1.26M.
  • Arcus Biosciences made up 0.02% of Fisher Asset Management's portfolio in Q2 2026, its #213 holding.
  • Fisher Asset Management first reported a position in Arcus Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.